Acute Myocardial Infarction with Lung Cancer during Treatment with Gefitinib: the Possibility of Gefitinib-Induced Thrombosis

Publisher： Karger

E-ISSN： 1424-8840|34|1|48-50

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.34, Iss.1, 2005-11, pp. : 48-50

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Gefitinib-Induced Hepatotoxicity in Patients Treated for Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 509-513

Karger

Access to resources Recommend Favorite

Erlotinib Achieved Partial Response in a Non-Small Cell Lung Cancer Patient with Gefitinib-Induced Interstitial Lung Disease

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 464-466

Karger

Access to resources Recommend Favorite

Eltrombopag Induced Thrombosis: A Case with Acute Myocardial Infarction

By  

Current Drug Safety, Vol. 11, Iss. 2, 2016-04 ,pp. : 174-176

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of Concomitant Medication Use on Gefitinib‐Induced Hepatotoxicity

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 2, 2018-02 ,pp. : 263-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erlotinib after Failure of Gefitinib Treatment of More Than 6 Months in Advanced Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 1-2, 2012-01 ,pp. : 8-9

Karger

Access to resources Recommend Favorite